Ceftaroline pharmacokinetics/pharmacodynamics in the hollow-fibre model of <i>Mycobacterium abscessus</i> lung disease
Ceftaroline-avibactam administered twice a day would be an adequate replacement for the four-times-a-day cefoxitin treatments for MAB-LD.
Authors
- Shashikant Srivastava (ORCID: https://orcid.org/0000-0002-8786-8851)
- Tawanda Gumbo (ORCID: https://orcid.org/0000-0001-7592-8012)
- Beatriz E. Ferro (ORCID: https://orcid.org/0000-0001-6045-1610)
Institutions
- Texas A&M University System (US)
- The University of Texas at Tyler (US)
- Practical Action (ZW)
- Icesi University (CO)
- The University of Texas Health Science Center at Tyler (US)
Publication Details
- Journal
- IJTLD OPEN
- Published
- 2025-09-01
- DOI
- https://doi.org/10.5588/ijtldopen.25.0173
- Citations
- 1
- Primary Topic
- Mycobacterium research and diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 1.35